Is Cencora Stock Underperforming the Dow?

Conshohocken, Pennsylvania-based Cencora, Inc. (COR) sources and distributes pharmaceutical products in the United States and internationally. Valued at a market cap of $61.6 billion, the company distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, and more.

Companies with a market cap of $10 billion or more are typically referred to as “large-cap stocks.” COR fits perfectly into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the medical distribution industry.